761 related articles for article (PubMed ID: 8889982)
1. Fluid homeostasis after heart transplantation: the role of cardiac denervation.
Braith RW; Mills RM; Wilcox CS; Convertino VA; Davis GL; Limacher MC; Wood CE
J Heart Lung Transplant; 1996 Sep; 15(9):872-80. PubMed ID: 8889982
[TBL] [Abstract][Full Text] [Related]
2. Endocrine response to plasma volume expansion during the early postoperative period in heart transplant recipients.
Mertes PM; de Talancé N; Carteaux JP; Pinelli G; Dopff C; Burtin P; Villemot JP; Burlet C; Boulangé M
J Heart Lung Transplant; 1993; 12(6 Pt 1):1001-8. PubMed ID: 8312300
[TBL] [Abstract][Full Text] [Related]
3. Breakdown of blood pressure and body fluid homeostasis in heart transplant recipients.
Braith RW; Mills RM; Wilcox CS; Davis GL; Wood CE
J Am Coll Cardiol; 1996 Feb; 27(2):375-83. PubMed ID: 8557909
[TBL] [Abstract][Full Text] [Related]
4. Neuroendocrine response to cardiac transplantation.
Masters RG; Davies RA; Keon WJ; Walley VM; Koshal A; de Bold AJ
Can J Cardiol; 1993 Sep; 9(7):609-17. PubMed ID: 8221359
[TBL] [Abstract][Full Text] [Related]
5. Effects of sodium intake on plasma potassium and renin angiotensin aldosterone system in conscious dogs.
Kjolby MJ; Kompanowska-Jezierska E; Wamberg S; Bie P
Acta Physiol Scand; 2005 Jul; 184(3):225-34. PubMed ID: 15954990
[TBL] [Abstract][Full Text] [Related]
6. Normal short-term renal response to acute volume expansion in heart transplant recipients: a role for atrial natriuretic peptide?
Geny B; Charloux A; Schaefer A; Brandt C; Charpentier A; Kretz JG; Eisenmann B; Haberey P; Piquard F
J Heart Lung Transplant; 1998 Nov; 17(11):1081-8. PubMed ID: 9855447
[TBL] [Abstract][Full Text] [Related]
7. High dose angiotensin-converting enzyme inhibition prevents fluid volume expansion in heart transplant recipients.
Braith RW; Mills RM; Wilcox CS; Mitchell MJ; Hill JA; Wood CE
J Am Coll Cardiol; 2000 Aug; 36(2):487-92. PubMed ID: 10933362
[TBL] [Abstract][Full Text] [Related]
8. Abnormal neuroendocrine responses during exercise in heart transplant recipients.
Braith RW; Wood CE; Limacher MC; Pollock ML; Lowenthal DT; Phillips MI; Staples ED
Circulation; 1992 Nov; 86(5):1453-63. PubMed ID: 1423959
[TBL] [Abstract][Full Text] [Related]
9. Relationship between blood pressure and renin, angiotensin II and atrial natriuretic factor after renal transplantation.
Hestin D; Mertes PM; Hubert J; Claudon M; Mejat E; Renoult E; Pertek JP; Frimat L; Burlet C; Kessler M
Clin Nephrol; 1997 Aug; 48(2):98-103. PubMed ID: 9285146
[TBL] [Abstract][Full Text] [Related]
10. Verapamil sustained-release in renal parenchymal hypertension: effect on blood pressure, kidney function, angiotensin II, aldosterone, arginine vasopressin, atrial natriuretic peptide, and lipoproteins.
Eiskjaer H; Pedersen EB; Rasmussen LM; Jespersen B
J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S17-22. PubMed ID: 2475677
[TBL] [Abstract][Full Text] [Related]
11. Family history and pathophysiological mechanisms of primary hypertension. Studies in non-hypertensive young men with positive and negative family histories of hypertension.
Widgren BR
Scand J Urol Nephrol Suppl; 1991; 134():1-75. PubMed ID: 1887213
[TBL] [Abstract][Full Text] [Related]
12. Flight influence on the plasma level of renin-angiotensin-aldosterone system and atrial natriuretic peptide.
Wang YM; Sheng DY
Aviat Space Environ Med; 1990 Nov; 61(11):999-1001. PubMed ID: 2147850
[TBL] [Abstract][Full Text] [Related]
13. Effects of cyclosporine on the renin-angiotensin-aldosterone system and potassium excretion in renal transplant recipients.
Bantle JP; Nath KA; Sutherland DE; Najarian JS; Ferris TF
Arch Intern Med; 1985 Mar; 145(3):505-8. PubMed ID: 3883934
[TBL] [Abstract][Full Text] [Related]
14. Renal response to volume expansion in heart-transplant and kidney-transplant recipients.
Pruszczynski W; Drieu L; Cabrol C; Rondeau E; Ardaillou R
Clin Nephrol; 1987 Aug; 28(2):65-72. PubMed ID: 3308232
[TBL] [Abstract][Full Text] [Related]
15. [Neurohormonal activation in congestive heart failure: does it normalize after heart transplantation?].
Pérez-Villa F; Roig E; Ferrer E; Cuppoletti A; Llancaqueo M; Jiménez W; Sanz G
Rev Esp Cardiol; 2004 Aug; 57(8):725-31. PubMed ID: 15282060
[TBL] [Abstract][Full Text] [Related]
16. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
Jensen J; Henik RA; Brownfield M; Armstrong J
Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
[TBL] [Abstract][Full Text] [Related]
17. Persistent alterations of vasopressin and N-terminal proatrial natriuretic peptide plasma levels in long-term abstinent alcoholics.
Döring WK; Herzenstiel MN; Krampe H; Jahn H; Pralle L; Sieg S; Wegerle E; Poser W; Ehrenreich H
Alcohol Clin Exp Res; 2003 May; 27(5):849-61. PubMed ID: 12766631
[TBL] [Abstract][Full Text] [Related]
18. Influence of erythropoietin treatment on plasma renin activity, aldosterone, vasopressin and atrial natriuretic peptide in haemodialyzed patients.
Kokot F; Wiecek A; Grzeszczak W; Klin M
Miner Electrolyte Metab; 1990; 16(1):25-9. PubMed ID: 2139159
[TBL] [Abstract][Full Text] [Related]
19. Atrial natriuretic peptide in hepatic cirrhosis: relation to stage of disease, sympathoadrenal system and renin-aldosterone axis.
Burghardt W; Wernze H; Diehl KL
Klin Wochenschr; 1986; 64 Suppl 6():103-7. PubMed ID: 2948055
[TBL] [Abstract][Full Text] [Related]
20. Calf muscle haemodynamics and the renin-angiotensin-aldosterone system in normotensive subjects with a familial predisposition to hypertension: changes during increased salt intake.
Gudmundsson O; Andersson OK; Aurell M; Wikstrand JM; Berglund GL
J Hypertens; 1984 Jun; 2(3):291-6. PubMed ID: 6397530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
